[Cancer genomes: where do we go from here?].
In recent years there has been an exponential growth of knowledge of the molecular basis of cancer. In particular, the creation of important initiatives for the elucidation of the genomes of several types of cancer has allowed for the first time the creation of catalogs for most mutational events in diverse tumors, which opens up significant opportunities for oncology and public health. This review provides an overview of the progress and possible directions in Mexico.
Subdirección de Investigación Básica, Instituto Nacional de Medicina Genómica, México, D.F.
Jorge
J
Meléndez-Zajgla
Subdirección de Investigación Médica, Instituto Nacional de Medicina Genómica, México, D.F.
Vilma
V
Maldonado Lagunas
D030541:Databases, Genetic; D006801:Humans; D008800:Mexico; D058990:Molecular Targeted Therapy; D009154:Mutation; D009369:Neoplasms / Q000235:genetics* / Q000628:therapy